ARCHIVES

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

This article is from The Cancer Letter archive.

Vol. 18 No. 23 | June 5, 1992

Download PDF Visit The Full Archive

Related Articles

Genasense Added To Chemo Improves Responses in CLL

December 31, 2004

GAO Report To Include Some But Not all Of Obey’s Charges

June 24, 1977

Beta Carotene Doesn’t Help, May Hurt, Two Trials Find

January 26, 1996

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990

Duke Vice Dean Cuffe Promises Complete, Independent Probe Of Work By Potti, Nevins.

July 30, 2010

Biomedical Panel To Hear Public At Sept. Meeting

July 11, 1975